SCHEMBL5376476

SCHEMBL5376476

C1=CCC(OCC2COC3(OC2)OCC(COC2CC=CCC2)CO3)CC1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.30
JAK1 P23458 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5388242 0.83 MAPK1 (0.38)
SCHEMBL18548798 0.75 TSHR (0.38)
SCHEMBL5384642 0.72 KDM4E (0.33)
SCHEMBL17601886 0.69 ALDH1A1 (0.34)
SCHEMBL11798011 0.69 ALDH1A1 (0.34)
SCHEMBL23361656 0.66
SCHEMBL3678284 0.66
SCHEMBL13406584 0.66
SCHEMBL15602733 0.66 CTSL (0.46)
SCHEMBL14627806 0.66 CTSL (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7232852-B2 Photopolymerizable compositions that include alicyclic/aromatic dioxiranes and novel dioxiranyl tetraoxaspiro [5.5] undecanes CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2007-06-19 US claimed
US-20040167245-A1 Photopolymerizable compositions that include alicyclic/aromatic dioxiranes and novel dioxiranyl tetraoxaspiro [5.5] undecanes CURATORS OF THE UNIVERSITY OF MISSOURI 2004-08-26 US claimed
US-20030187093-A1 Photopolymerizable compositions that include alicyclic/aromatic dioxiranes and novel dioxiranyl tetraoxaspiro [5.5] undecanes CURATORS OF THE UNIVERSITY 2003-10-02 US claimed
US-7232852-B2 Photopolymerizable compositions that include alicyclic/aromatic dioxiranes and novel dioxiranyl tetraoxaspiro [5.5] undecanes CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2007-06-19 US disclosed
US-7232852-B2 Photopolymerizable compositions that include alicyclic/aromatic dioxiranes and novel dioxiranyl tetraoxaspiro [5.5] undecanes CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2007-06-19 US disclosed
US-6825364-B2 DENTISTRY REGENERATION CURATORS OF THE UNIVERSITY OF MISSOURI 2004-11-30 US disclosed
US-20040167245-A1 Photopolymerizable compositions that include alicyclic/aromatic dioxiranes and novel dioxiranyl tetraoxaspiro [5.5] undecanes CURATORS OF THE UNIVERSITY OF MISSOURI 2004-08-26 US disclosed
US-20030187093-A1 Photopolymerizable compositions that include alicyclic/aromatic dioxiranes and novel dioxiranyl tetraoxaspiro [5.5] undecanes CURATORS OF THE UNIVERSITY 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187093-A1 Photopolymerizable compositions that include alicyclic/aromatic dioxiranes and novel dioxiranyl tetraoxaspiro [5.5] undecanes NT5C, WDR5, DHX15 JAK2 3670/4885JAK1 3915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.